Verity & Verity’s Cardinal Health CAH Stock Holding History

Verity & Verity’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,426	Closed	-$239K	–	117
2024 Q2	$239K	Buy	+2,426	New	+$247K	0.03%	111

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Verity & Verity's CAH Position: Q3 2024 in Review

Verity & Verity sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 2,426 shares — an estimated $239K sold.

Verity & Verity first reported a position in CAH in Q2 2024 and held it in 1 quarter. The position peaked at $239K in Q2 2024. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

Verity & Verity reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
Verity & Verity sold 2,426 Cardinal Health shares in Q3 2024, an estimated $239K.
Verity & Verity first reported a position in Cardinal Health in Q2 2024 and held it in 1 quarter.
Verity & Verity's Cardinal Health position peaked at $239K in Q2 2024.
1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Verity & Verity's 13F filing for Q3 2024, filed 7 Nov 2024.